阵发性心房颤动患者植入心肌收缩力调节器1例Use of cardiac contractility modulation in a patient with paroxysmal atrial fibrillation
樊楚轩,吴明祥,苏晞
摘要(Abstract)：
心肌收缩力调节器（CCM）是以2导线或3导线工作方式提供心肌收缩力调节的疗法，适用于不适合心脏再同步化治疗（CRT）、左心室射血分数（LVEF）25%～45%、接受药物治疗仍有症状的纽约心脏病协会（NYHA）心功能分级Ⅲ级心力衰竭患者。国内少有心房颤动患者CCM植入报道，本文报道对1例阵发性心房颤动患者植入CCM治疗心力衰竭。
关键词(KeyWords)： 心力衰竭;心房颤动;心房扑动;心肌收缩力调节器
基金项目(Foundation): 无导线起搏器与传统起搏器临床应用的有效性和安全性研究（WX21D79）
作者(Author): 樊楚轩,吴明祥,苏晞
参考文献(References)：
- [1]郭继鸿.无休止性心动过速[J].临床心电学杂志，2000,9(3):178-183.
- [2]中国心衰中心联盟，苏州工业园区心血管健康研究院，中国心血管健康联盟.中国心衰中心工作报告（2021）——心力衰竭患者的诊疗现况[J].中国介入心脏病学杂志，2022,30(5):328-336. DOI:10.3969/j.issn.1004-8812.2022.05.002.
- [3]张峥，李佳雨，白元.心房心肌病与缺血性卒中的研究进展[J].中国介入心脏病学杂志，2022,30(3):199-202. DOI:10.3969/j.issn.1004-8812.2022.03.007.
- [4] Kahwash R, Burkhoff D, Abraham WT. Cardiac contractility modulation in patients with advanced heart failure[J]. Expert Rev Cardiovasc Ther,2013,11(5):635-645. DOI:10.1586/erc.13.48.
- [5] Brunckhorst CB, Shemer I, Mika Y, et al. Cardiac contractility modulation by non-excitatory currents:studies in isolated cardiac muscle[J]. Eur J Heart Fail,2006,8(1):7-15. DOI:10.1016/j.ejheart.2005.05.011.
- [6] Abraham WT, Kuck KH, Goldsmith RL, et al. A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation[J]. JACC Heart Fail,2018,6(10):874-883. DOI:10.1016/j.jchf.2018.04.010.
- [7] Yu CM, Chan JY, Zhang Q, et al. Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling[J]. JACC Cardiovasc Imaging,2009,2(12):1341-1349. DOI:10.1016/j.jcmg.2009.07.011.
- [8] Imai M, Rastogi S, Gupta RC, et al. Therapy with cardiac contractility modulation electrical signals improves left ventricular function and remodeling in dogs with chronic heart failure[J].J Am Coll Cardiol, 2007, 49(21):2120-2128. DOI:10.1016/j.jacc.2006.10.082.
- [9] Butter C, Rastogi S, Minden HH, et al. Cardiac contractility modulation electrical signals improve myocardial gene expression in patients with heart failure[J]. J Am Coll Cardiol, 2008,51(18):1784-1789. DOI:10.1016/j.jacc.2008.01.036.
- [10] Wiegn P, Chan R, Jost C, et al. Safety, performance,and efficacy of cardiac contractility modulation delivered by the2-lead optimizer smart system:the FIX-HF-5C2 study[J].Circ Heart Fail, 2020, 13(4):e006512. DOI:10.1161/CIRCHEARTFAILURE.119.006512.
- [11] R?ger S, Schneider R, Rudic B, et al. Cardiac contractility modulation:first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation[J].Europace, 2014, 16(8):1205-1209. DOI:10.1093/europace/euu050.
- [12] Kuschyk J, Falk P, Demming T, et al. Long-term clinical experience with cardiac contractility modulation therapy delivered by the Optimizer Smart system[J]. Eur J Heart Fail, 2021,23(7):1160-1169.DOI:10.1002/ejhf.2202.
- [13] Uskach TM, Tereshchenko SN, Pavlenko TA,et al. Possibilities and perspectives of using cardiac contractility modulation in patients with chronic heart failure and atrial fibrillation[J].Kardiologiia,2019, 59(2S):4-14. DOI:10.18087/cardio.2616.